# Unisurge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/unisurge

- Industry: Medical Devices & Equipment
- Headquarters: Cupertino, US
- Website: www.unisurge.com
- Latest round: Series B (Mar 19, 1992)
- Investors on record: 7

## About

Unisurge, Inc. is a medical supply company specializing in the production of Custom Surgical Procedure Trays and a variety of surgical products designed for hospital use, addressing the essential needs of healthcare professionals.Founded in 1990 and headquartered in Cupertino, US, Unisurge, Inc. focuses on manufacturing medical products tailored for surgical settings. The company has strategically remained consistent in its core operations without significant pivots or changes. Arash Farboud, one of the co-founders, has a background in the medical supply industry, enhancing the firm's expertise. In March 1992, Unisurge secured a Series B financing round from notable investors including C. R. Bard and Sequoia Capital, marking its first significant funding event.Unisurge International Limited specializes in manufacturing and supplying practitioner-specified Custom Surgical Procedure Trays (CPT), along with a diverse range of medical products tailored for hospital environments. Their core offerings include surgical drapes, gowns, instruments, laparoscopic instruments, and medical/ward dressing packs, all designed to meet the stringent needs of healthcare professionals. These products are utilized in various surgical settings, including anaesthetics, thoracic surgery, orthopaedics, neurosurgery, and more. Unisurge’s client base primarily consists of hospitals and healthcare facilities across the United Kingdom and various international markets, where they address the critical need for high-quality, reliable surgical supplies. The company’s products are developed in certified clean room environments, ensuring adherence to industry standards and enhancing patient safety.Unisurge International Limited generates revenue through direct sales of its medical products to hospitals and healthcare providers, employing a business-to-business (B2B) transaction structure. The firm offers a range of specialized products under its flagship lines, including the Formula range and Custom Procedure Packs, which are specifically tailored to the operational needs of healthcare practitioners. Transactions typically involve bulk orders, with clients selecting from a catalogue of offerings that include surgical drapes, gowns, and instruments, ensuring that healthcare settings are adequately equipped for various procedures. Pricing structures are established based on product types and quantities ordered, facilitating straightforward procurement for hospitals and medical facilities. This transactional model supports Unisurge’s position as a key supplier in the medical sector, enabling the firm to maintain consistent revenue flow through repeat orders and long-term partnerships with healthcare institutions.Unisurge, Inc. is focused on expanding its product line with new offerings designed to meet emerging healthcare needs, although specific product launch dates have yet to be disclosed. The company is also exploring opportunities to penetrate additional international markets, particularly within Europe and Asia, by 2024. The recent funding round, completed in March 1992, will be utilized to support these expansion efforts, enhancing product development and market outreach strategies.

## Funding rounds

- Series B, Mar 19, 1992 — Delphi Ventures, Hong Shan, Technology Partners, Venrock, Vertical Group, C. R. Bard, Inc., Volpe, Welte & Co.

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series B
- Hong Shan — Series B
- Technology Partners — Series B
- Venrock (https://capitalatlas.ai/funds/venrock) — Series B
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series B
- C. R. Bard, Inc. — Series B
- Volpe, Welte & Co. — Series B